Robin Marsden
Corporate Officer/Principal chez REVELATION BIOSCIENCES, INC.
Provenance du réseau au premier degré de Robin Marsden
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Robin Marsden via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| GILEAD SCIENCES, INC. | Biotechnology | Corporate Officer/Principal | |
SEQUUS Pharmaceuticals, Inc.
 SEQUUS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology SEQUUS Pharmaceuticals, Inc. is based in Menlo Park, CA. Part of Johnson & Johnson, SEQUUS Pharmaceuticals, Inc. is a company that markets lipid-based biopharmaceutical products mainly to treat cancer and infectious diseases. SEQUUS Pharmaceuticals was acquired by ALZA Corp., part of Johnson & Johnson from June 22, 2001 on March 16, 1999 for $658.03 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Alpha-Beta Technology, Inc.
 Alpha-Beta Technology, Inc. Electronic ComponentsElectronic Technology Alpha-Beta Technology, Inc. engages in the discovery, development and commercialization of novel carbohydrate-based products for the prevention and treatment of infectious disease. It develops a novel class of immune modulation pharmaceutical products composed of complex carbohydrates and is discovering and developing new anti-fungal diagnostics and drugs. In addition, Alpha-Beta has developed a rapid in vitro diagnostic to detect and monitor systemic fungal infections and has an anti-fungal research program to discover direct inhibitors of fungal cell wall synthesis. It is in the development stage and is devoting substantially all of its efforts toward product research and development, raising capital, marketing products under development, clinical trials and manufacturing. The Company was founded on March 2, 1988 and is headquartered in Worcester, MA. | Electronic Components | Corporate Officer/Principal | |
| LA JOLLA PHARMACEUTICAL COMPANY | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Chief Operating Officer Investor Relations Contact | |
| BIOLASE, INC. | Medical Specialties | Director/Board Member | |
| SPECTRUM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| NGEN INC | Medical Specialties | Comptroller/Controller/Auditor | |
Allos Therapeutics, Inc.
 Allos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allos Therapeutics, Inc. is a biopharmaceutical company committed to the development and commercialization of innovative anti-cancer therapeutics. It focuses on the development and commercialization FOLOTYN a pralatrexate injection. FOLOTYN is a folate analogue metabolic inhibitor designed to accumulate preferentially in cancer cells. It targets the inhibition of dihydrofolate reductase, or DHFR, an enzyme critical in the folate pathway, thereby interfering with DNA and RNA synthesis and triggering cancer cell death. Allos Therapeutics is also developing FOLOTYN in other hematologic malignancies and solid tumors. The company was founded on September 1, 1992 and is headquartered in Westminster, CO. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SeraCare Life Sciences, Inc.
 SeraCare Life Sciences, Inc. Medical SpecialtiesHealth Technology SeraCare Life Sciences, Inc. provides in vitro diagnostics and clinical laboratory products. It supplies diagnostic quality controls, biological materials, and reagents to in vitro diagnostics developers, clinical laboratories, and life science researchers. The firm’s products include Next-Gen Sequencing and Digital PCR Tools, Controls and Reference Materials, Validation and Lot Qualification Materials, Plasma and Serum Diluents/Derivatives, Cell Culture Reagents, KPL Antibodies and Conjugates and KPL Immunoassay Reagents and Kits. The company was founded in 1984 and is headquartered in Milford, MA. | Medical Specialties | Director of Finance/CFO | |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Revelation Biosciences Sub, Inc.
 Revelation Biosciences Sub, Inc. Medical SpecialtiesHealth Technology Part of Revelation Biosciences, Inc., Revelation Biosciences Sub, Inc. develops medical devices. The company is based in San Diego, CA. James M. Rolke has been the CEO of the company since 2020. Revelation Biosciences Sub was acquired by Petra Acquisition, Inc. on January 11, 2022 for $87.36 million. | Medical Specialties | Chairman Director/Board Member Chief Executive Officer Director/Board Member | |
Revelation Therapeutics LLC
 Revelation Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Revelation Therapeutics LLC provides biotechnology services. The company is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Director of Finance/CFO Director/Board Member | |
Z3 Capital LLC
 Z3 Capital LLC Real Estate Investment TrustsFinance Z3 Capital LLC provides real estate investment services. | Real Estate Investment Trusts | Corporate Officer/Principal | |
Symmetry Advisors
 Symmetry Advisors Investment ManagersFinance Symmetry Advisors provides investment advisory services. The private company is based in San Diego, CA. | Investment Managers | Corporate Officer/Principal | |
| Keene State College | College/University | Undergraduate Degree | |
| MERSANA THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| Surgical Sealants, Inc. | Corporate Officer/Principal | ||
| Geltex, Inc. | Corporate Officer/Principal | ||
| Eastern University | College/University | Undergraduate Degree | |
| George Washington University | College/University | Corporate Officer/Principal | |
| VA Medical Center (District of Columbia) | General Government | Corporate Officer/Principal | |
CalciMedica, Inc. (US)
 CalciMedica, Inc. (US) BiotechnologyHealth Technology CalciMedica, Inc. is a holding company, which engages in drug development. It discovers and develops novel small molecule drugs for the treatment of inflammatory and autoimmune disorders and organ transplant rejection. The company was founded by Gonul Velicelebi, Kenneth Stauderman, Anjana Rao, Patrick Hogan, Stefan Feske, Michael Harpold, Tom Reed, and Jack Roos in December 2006 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member | |
| New Jersey Medical School | College/University | Doctorate Degree | |
| Boston University | College/University | Undergraduate Degree | |
ExThera Medical Corp.
 ExThera Medical Corp. Medical/Nursing ServicesHealth Services ExThera Medical Corp. develops medical devices that address unmet clinical needs in the treatment of bloodstream infections and pathogen-reduction in blood banking. The company develops Seraph Microbind Affinity Blood Filter (Seraph), which captures and removes normal and drug-resistant bacteria, viruses, toxins, and pro-inflammatory cytokines from human blood; and offers solution for use in a dialysis, such as extracorporeal circuit for treating existing bloodstream infections. The company was founded in 2007 and is headquartered in Martinez, CA. | Medical/Nursing Services | Director/Board Member | |
| The University of Colorado | College/University | Masters Business Admin | |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kartos Therapeutics, Inc. is a clinical stage biopharmaceutical company based in Redwood City, CA. Kartos Therapeutics, Inc. is focused on developing a potential MDM2 inhibitor for the treatment of various TP53 wild-type hematological malignancies and solid tumors. The company was founded by Wayne P. Rothbaum and Iain David Dukes, and the CEO is Jesse Seton McGreivy. | Pharmaceuticals: Major | Chief Operating Officer | |
| Zicklin School of Business | College/University | Graduate Degree | |
Corporate Directors Forum
 Corporate Directors Forum Miscellaneous Commercial ServicesCommercial Services Corporate Directors Forum operates as a forum for corporate directors. The non-profit company is based in La Jolla, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree | |
InfaCare Pharmaceutical Corp.
 InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Biotechnology | Director/Board Member | |
| ANAVEX LIFE SCIENCES CORP. | Biotechnology | Director/Board Member | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal | |
| ODONATE, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Lucile Packard Foundation for Children’s Health | Investment Trusts/Mutual Funds | Director/Board Member | |
| DEXCOM, INC. | Medical Specialties | Director of Finance/CFO | |
| San Diego State University | College/University | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 45 |
| Canada | 2 |
Sectorielle
| Health Technology | 24 |
| Consumer Services | 11 |
| Commercial Services | 5 |
| Health Services | 3 |
| Finance | 3 |
Opérationnelle
| Director/Board Member | 20 |
| Corporate Officer/Principal | 18 |
| Chief Executive Officer | 7 |
| Founder | 6 |
| Independent Dir/Board Member | 6 |
Relations les plus connectées
| Insiders | |
|---|---|
| George Tidmarsh | 22 |
| James Rolke | 12 |
| Jess Roper | 9 |
| Chester Zygmont | 8 |
| Lakhmir Chawla | 8 |
| Jennifer Carver | 7 |
| Sandra Vedrick | 3 |
- Bourse
- Insiders
- Robin Marsden
- Connexions Sociétés